Insilico Jumps After Signing Deal to Develop Biology AI Models Worth Tens of Millions of US Dollars

Insilico Medicine signed a multi-million dollar deal with an AI foundation model lab to jointly develop and commercialize advanced AI models tailored for biological research, leveraging its MAI Gym training framework and proprietary datasets. The collaboration includes wet-lab validation and revenue-sharing, enhancing Insilico's AI-driven drug discovery capabilities.

This Wire brief sits within Fusion42's coverage of Biotech.